Wellington Management Group LLP Grows Holdings in Mettler-Toledo International, Inc. $MTD

Wellington Management Group LLP boosted its position in Mettler-Toledo International, Inc. (NYSE:MTD) by 908.6% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 459,064 shares of the medical instruments supplier’s stock after acquiring an additional 413,547 shares during the quarter. Wellington Management Group LLP’s holdings in Mettler-Toledo International were worth $586,459,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. XXEC Inc. bought a new stake in Mettler-Toledo International during the 2nd quarter valued at $77,044,000. BlackRock Inc. acquired a new position in Mettler-Toledo International during the 2nd quarter worth $2,404,713,000. Capital International Investors grew its stake in shares of Mettler-Toledo International by 12.7% in the fourth quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock worth $1,351,064,000 after purchasing an additional 109,508 shares in the last quarter. T. Rowe Price Investment Management Inc. increased its holdings in shares of Mettler-Toledo International by 0.5% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 691,565 shares of the medical instruments supplier’s stock valued at $964,174,000 after purchasing an additional 3,157 shares during the period. Finally, Geode Capital Management LLC increased its holdings in shares of Mettler-Toledo International by 2.4% during the fourth quarter. Geode Capital Management LLC now owns 597,448 shares of the medical instruments supplier’s stock valued at $830,879,000 after purchasing an additional 14,106 shares during the period. 95.07% of the stock is owned by institutional investors.

Insider Transactions at Mettler-Toledo International

In other news, insider Gerry Keller sold 240 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $1,427.14, for a total value of $342,513.60. Following the transaction, the insider owned 259 shares of the company’s stock, valued at $369,629.26. The trade was a 48.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Thomas P. Salice sold 417 shares of the business’s stock in a transaction that occurred on Wednesday, August 5th. The stock was sold at an average price of $1,440.41, for a total transaction of $600,650.97. Following the completion of the sale, the director owned 292 shares in the company, valued at $420,599.72. The trade was a 58.82% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 3,312 shares of company stock valued at $4,750,362 in the last quarter. Insiders own 0.71% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on MTD shares. Citigroup reduced their price objective on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating for the company in a report on Friday, May 8th. JPMorgan Chase & Co. lowered their target price on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Wall Street Zen downgraded shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Stifel Nicolaus upped their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research note on Monday, August 3rd. Finally, Morgan Stanley raised their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,450.00 and gave the company an “equal weight” rating in a research note on Tuesday, August 4th. Six analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $1,461.27.

Mettler-Toledo International Trading Down 0.7%

Shares of MTD stock opened at $1,397.03 on Friday. The stock has a 50-day simple moving average of $1,345.25 and a 200 day simple moving average of $1,275.03. Mettler-Toledo International, Inc. has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,525.17. The stock has a market capitalization of $28.00 billion, a P/E ratio of 31.44, a P/E/G ratio of 2.88 and a beta of 1.23. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 159.45.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 EPS for the quarter, topping the consensus estimate of $10.78 by $0.68. Mettler-Toledo International had a net margin of 21.91% and a negative return on equity of 1,212.14%. The firm had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same period in the previous year, the business earned $10.09 earnings per share. Mettler-Toledo International’s revenue for the quarter was up 4.5% compared to the same quarter last year. On average, sell-side analysts expect that Mettler-Toledo International, Inc. will post 47.35 earnings per share for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.